Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunsuke Nashimoto

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 4, 2025
Optimization of voriconazole dosage via population pharmacokinetic analysis based on the albumin-bilirubin (ALBI) score of patients with liver dysfunctionShunsuke Nashimoto, Mitsuru Sugawara, Yoh Takekuma
Biological & Pharmaceutical Bulletin|February 1, 2023
Usefulness of the Albumin-Bilirubin Score in Determining the Initial Dose of Voriconazole for Patients with Liver CirrhosisShunsuke Nashimoto, Shungo Imai, Mitsuru Sugawara, et al.
Biopharmaceutics & Drug Disposition|December 28, 2016
Inhibitory effect of ezetimibe can be prevented by an administration interval of 4 h between α-tocopherol and ezetimibeShunsuke Nashimoto, Yuki Sato, Yoh Takekuma, et al.
European Journal of Clinical Pharmacology|March 18, 2026
Creatinine- and cystatin C-based population pharmacokinetic models for predicting mycophenolic acid clearance in patients with autoimmune diseasesShunsuke Nashimoto, Masashi Miyamae, Shun Onodera, et al.
Drug Metabolism and Pharmacokinetics|October 10, 2020
Transport via Niemann-Pick C1 Like 1 contributes to the intestinal absorption of ubiquinoneShunsuke Nashimoto, Yuto Takekawa, Yoh Takekuma, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 27, 2023
Monitoring Salivary Concentrations of Tedizolid and Linezolid Using RatsYuki Inoue, Yuki Sato, Hitoshi Kashiwagi, et al.
International Journal of Clinical Pharmacy|October 4, 2024
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation studyYuki Inoue, Hitoshi Kashiwagi, Yuki Sato, et al.
Biological & Pharmaceutical Bulletin|March 20, 2024
Platelets Affect the Activity of Amino Acid Transporter SNAT4 in HuH-7 Human Hepatoma CellsHitoshi Kashiwagi, Yuki Sato, Shunsuke Nashimoto, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 12, 2018
Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery systemYuki Sato, Tatsuru Joumura, Shunsuke Nashimoto, et al.
Biological & Pharmaceutical Bulletin|May 31, 2023
Risk Factor Analysis of Vancomycin-Induced Nephrotoxicity in Paediatric Patients Aged 0-1 Year Using Japanese Medical DatabaseTakayuki Miyai, Yoh Takekuma, Hitoshi Kashiwagi, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 4, 2025
Optimization of voriconazole dosage via population pharmacokinetic analysis based on the albumin-bilirubin (ALBI) score of patients with liver dysfunctionShunsuke Nashimoto, Mitsuru Sugawara, Yoh Takekuma
Biological & Pharmaceutical Bulletin|February 1, 2023
Usefulness of the Albumin-Bilirubin Score in Determining the Initial Dose of Voriconazole for Patients with Liver CirrhosisShunsuke Nashimoto, Shungo Imai, Mitsuru Sugawara, et al.
Biopharmaceutics & Drug Disposition|December 28, 2016
Inhibitory effect of ezetimibe can be prevented by an administration interval of 4 h between α-tocopherol and ezetimibeShunsuke Nashimoto, Yuki Sato, Yoh Takekuma, et al.
European Journal of Clinical Pharmacology|March 18, 2026
Creatinine- and cystatin C-based population pharmacokinetic models for predicting mycophenolic acid clearance in patients with autoimmune diseasesShunsuke Nashimoto, Masashi Miyamae, Shun Onodera, et al.
Drug Metabolism and Pharmacokinetics|October 10, 2020
Transport via Niemann-Pick C1 Like 1 contributes to the intestinal absorption of ubiquinoneShunsuke Nashimoto, Yuto Takekawa, Yoh Takekuma, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 27, 2023
Monitoring Salivary Concentrations of Tedizolid and Linezolid Using RatsYuki Inoue, Yuki Sato, Hitoshi Kashiwagi, et al.
International Journal of Clinical Pharmacy|October 4, 2024
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation studyYuki Inoue, Hitoshi Kashiwagi, Yuki Sato, et al.
Biological & Pharmaceutical Bulletin|March 20, 2024
Platelets Affect the Activity of Amino Acid Transporter SNAT4 in HuH-7 Human Hepatoma CellsHitoshi Kashiwagi, Yuki Sato, Shunsuke Nashimoto, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 12, 2018
Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery systemYuki Sato, Tatsuru Joumura, Shunsuke Nashimoto, et al.
Biological & Pharmaceutical Bulletin|May 31, 2023
Risk Factor Analysis of Vancomycin-Induced Nephrotoxicity in Paediatric Patients Aged 0-1 Year Using Japanese Medical DatabaseTakayuki Miyai, Yoh Takekuma, Hitoshi Kashiwagi, et al.
Pageof 3